[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342506-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342506-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","systematic-pan-cancer-analyses-of-the-potential-function-of-the-golgi-scaffold-protein-paqr3","Systematic pan-cancer analyses of the potential function of the Golgi scaffold protein PAQR3","","This study systematically evaluates the prognostic and therapeutic value of the Golgi scaffold protein PAQR3 across 31 tumor types. Using multiple public resources including TCGA, UALCAN, GEO, GEPIA2, TIMER, Kaplan–Meier plotter, and TISIDB, it maps PAQR3 expression differences between tumor and normal tissues and links PAQR3 levels to overall survival and disease-related outcomes in multiple cancers. The work characterizes PAQR3 genetic alterations, correlates PAQR3 with tumor mutation load, microsatellite instability, neoantigens, and purity, and highlights a potential impact on the tumor microenvironment and chemotherapy responsiveness.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/systematic-pan-cancer-analyses-of-the-potential-function-of-the-golgi-scaffold-protein-paqr3/342506/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/systematic-pan-cancer-analyses-of-the-potential-function-of-the-golgi-scaffold-protein-paqr3/342506.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-17","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How was PAQR3 evaluated across cancers in this study?","Question",{"text":63,"@type":64},"PAQR3 was analyzed across 31 tumor types using multiple databases including TCGA, UALCAN, GEO, GEPIA2, TIMER, Kaplan–Meier plotter, and TISIDB to compare expression, prognosis, and genomic alterations.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What overall relationship did PAQR3 show with patient outcomes?",{"text":68,"@type":64},"PAQR3 expression correlated with survival outcomes in different directions depending on cancer type, with positive correlations reported in several cancers for OS and DSS and a negative correlation noted for rectum adenocarcinoma for OS.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the study find about PAQR3 mutations and their immunology relevance?",{"text":72,"@type":64},"PAQR3 alterations were associated with multiple mutation processes, with missense mutations being most common. The results also show PAQR3 links to tumor mutation load, microsatellite instability, neoantigens, and purity, suggesting an influence on the tumor microenvironment.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342506,1790194602,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nSystematic pan‑cancer analyses of the potential function  \nof the Golgi scaffold protein PAQR3  \nZhe‑Nan Ling1,2,3,4,5, Lian‑Lian Hong5, Jian Wu1,2,3,4* & Zhi‑Qiang Ling5,6*  \nProgesterone and AdipoQ Receptor 3 (PAQR3) is a member oftheAdipoQ receptor. Our previous studies have found that PAQR3 plays a role as a candidate inhibitor in cardiac adenocarcinoma, breast cancer, gastric cancer and colorectal cancer, but the systematic analysis of PAQR3 in tumors is currently lacking. The objective of this study was to investigate the prognostic and therapeutic value of PAQR3 in 31 tumors. Through the analysis of TCGA, UALCAN, GEO, GEPIA2, TIMER, Kaplan–Meier plotter, TISIDB and other databases, it was found that the expression level of PAQR3 changed significantly in different tumor types, and the expression level of Neuroblastoma was  \nvery high. And the level of Prostate adenocarcinoma is low. In addition, the expression level of PAQR3 inCholangiocarcinoma, Esophageal carcinoma, Head and neck squamous carcinoma, Liver Hepatocellular Carcinoma, Lung Adenocarcinoma and Lung squamous cell carcinoma was significantly higher than that in normal tissues. However, the expression level of PAQR3 in Breast Cancer, Kidney Renal Clear Cell Carcinoma, Kidney renal papillary cell carcinoma, Prostate Adenocarcinoma, Rectum Adenocarcinoma, Thyroid Cancer and Uterine Corpus Endometrial Carcinoma was lower than that in normal tissues. Subsequently, we explored the value of PAQR3 as a prognostic indicator of cancer. In Acute Myeloid Leukemia, Lower‑grade Glioma and Glioblastoma, Pediatric Low‑grade Gliomas, Kidney Chromophobe, and Thyroid Cancer, PAQR3 expression was positively correlated with OS and DSS, while in Rectum Adenocarcinoma, PAQR3 expression was negatively correlated with OS. PAQR3 high expression group Lower‑grade Glioma and Glioblastoma, Pediatric Low‑grade Gliomas, Uveal Melanoma, Kidney Chromophobe and DFI were positively correlated. PAQR3 can be used as a risk factor for the prognosis of multiple tumors. Then, we discussed the correlation between PAQR3 and immunology, and found that PAQR3 has a wide range of mutations in various tumor types, the most common mutation type is missense mutation, and common mutation types also include amplification, depth deletion, splicing, truncation and structural variation. Among the tumor samples with PAQR3 alterations, mutation occurred in all tumor samples except prostate adenocarcinoma and adrenal cortical carcinoma, head and neck squamous cell carcinoma, brain low‑grade glioma, and kidney clear cell carcinoma, while esophageal adenocarcinoma had the highest total alteration frequency. PAQR3 was strongly associated with CNV in 18 tumors, particularly in Ovarian cancer, Lung squamous cell carcinoma, and Adenoid cystic carcinoma. On the other hand, PAQR3 has a higher SNV frequency in Uterine Corpus Endometrial Carcinoma, Skin Cutaneous Melanoma and Lung Adenocarcinoma, among which Uterine Corpus Endometrial Carcinoma has the highest SNV frequency. These results showed that PAQR3 expression levels were significantly correlated with tumor mutation load, microsatellite instability, neoantigens, and purity. In summary, PAQR3 can affect the tumor microenvironment and has potential for chemotherapy. Finally, we investigated the role of PAQR3 in tumor resistance and found that the expression of PAQR3 affects the efficacy of multiple chemotherapy drugs. Based  \n1Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou 310003, Zhejiang, People’s Republic of China. 2NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, Zhejiang, People’s Republic of China. 3Key Laboratory of the Diagnosis and Treatment of Organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary an","cbCaip9xNCHlvLrN","https://ap.wps.com/l/cbCaip9xNCHlvLrN","pdf",23823249,27,"English","# Expression patterns across tumor types\n## Prognostic associations with OS and DSS\n# Genetic alterations and immunology links\n## Mutation types and alteration frequencies\n## Correlations with CNV, SNV, and tumor biomarkers\n# Implications for chemotherapy and tumor resistance","[{\"question\":\"How was PAQR3 evaluated across cancers in this study?\",\"answer\":\"PAQR3 was analyzed across 31 tumor types using multiple databases including TCGA, UALCAN, GEO, GEPIA2, TIMER, Kaplan–Meier plotter, and TISIDB to compare expression, prognosis, and genomic alterations.\"},{\"question\":\"What overall relationship did PAQR3 show with patient outcomes?\",\"answer\":\"PAQR3 expression correlated with survival outcomes in different directions depending on cancer type, with positive correlations reported in several cancers for OS and DSS and a negative correlation noted for rectum adenocarcinoma for OS.\"},{\"question\":\"What did the study find about PAQR3 mutations and their immunology relevance?\",\"answer\":\"PAQR3 alterations were associated with multiple mutation processes, with missense mutations being most common. The results also show PAQR3 links to tumor mutation load, microsatellite instability, neoantigens, and purity, suggesting an influence on the tumor microenvironment.\"}]","Systematic pan-cancer analyses of the potential function of the Golgi scaffold protein PAQR3 | PDF",1790046878,68,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/19f2593d896e48e3319fef2bd6588847.webp",983,1291,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c26c2d236cee9a256ee13cae62f21ae9.webp",982,1290,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3aca990da286f50e55bb44c954991b6c.webp",981,1289,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7db9d3baa51d566ba8d6ea596330256.webp",980,1287]